Your browser doesn't support javascript.
loading
Phenotypic and Imaging Spectrum Associated With WDR45.
Adang, Laura A; Pizzino, Amy; Malhotra, Alka; Dubbs, Holly; Williams, Catherine; Sherbini, Omar; Anttonen, Anna-Kaisa; Lesca, Gaetan; Linnankivi, Tarja; Laurencin, Chloé; Milh, Matthieu; Perrine, Charles; Schaaf, Christian P; Poulat, Anne-Lise; Ville, Dorothee; Hagelstrom, Tanner; Perry, Denise L; Taft, Ryan J; Goldstein, Amy; Vossough, Arastoo; Helbig, Ingo; Vanderver, Adeline.
Afiliación
  • Adang LA; Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Electronic address: adangl@email.chop.edu.
  • Pizzino A; Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Malhotra A; Illumina Clinical Services Laboratory, Illumina, Inc., San Diego, California.
  • Dubbs H; Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Williams C; Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Sherbini O; Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Anttonen AK; Folkhälsan Research Center, Helsinki, Finland; Medical and Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Lesca G; Department of Medical genetics, Lyon University Hospital, Bron, France.
  • Linnankivi T; Medical and Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Laurencin C; Hôpital Neurologique Pierre Wertheimer, Bron, France.
  • Milh M; Aix-Marseille Université, Marseille, France.
  • Perrine C; Hôpital de La Salpêtrière, Paris, France.
  • Schaaf CP; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.
  • Poulat AL; Department of Pediatric Neurology, Lyon University Hospital, Bron, France.
  • Ville D; Department of Pediatric Neurology, Lyon University Hospital, Bron, France.
  • Hagelstrom T; Illumina Clinical Services Laboratory, Illumina, Inc., San Diego, California.
  • Perry DL; Illumina Clinical Services Laboratory, Illumina, Inc., San Diego, California.
  • Taft RJ; Illumina Clinical Services Laboratory, Illumina, Inc., San Diego, California.
  • Goldstein A; Division of Metabolism, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Vossough A; Division of Neuroradiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Helbig I; Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; The Epilepsy NeuroGenetics Initiative (ENGIN), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Vanderver A; Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Pediatr Neurol ; 109: 56-62, 2020 08.
Article en En | MEDLINE | ID: mdl-32387008
ABSTRACT

BACKGROUND:

Mutations in the X-linked gene WDR45 cause neurodegeneration with brain iron accumulation type 5. Global developmental delay occurs at an early age with slow progression to dystonia, parkinsonism, and dementia due to progressive iron accumulation in the brain.

METHODS:

We present 17 new cases and reviewed 106 reported cases of neurodegeneration with brain iron accumulation type 5. Detailed information related to developmental history and key time to event measures was collected.

RESULTS:

Within this cohort, there were 19 males. Most individuals were molecularly diagnosed by whole-exome testing. Overall 10 novel variants were identified across 11 subjects. All individuals were affected by developmental delay, most prominently in verbal skills. Most individuals experienced a decline in motor and cognitive skills. Although most individuals were affected by seizures, the spectrum ranged from provoked seizures to intractable epilepsy. The imaging findings varied as well, often evolving over time. The classic iron accumulation in the globus pallidus and substantia nigra was noted in half of our cohort and was associated with older age of image acquisition, whereas myelination abnormalities were associated with younger age.

CONCLUSIONS:

WDR45 mutations lead to a progressive and evolving disorder whose diagnosis is often delayed. Developmental delay and seizures predominate in early childhood, followed by a progressive decline of neurological function. There is variable expressivity in the clinical phenotypes of individuals with WDR45 mutations, suggesting that this gene should be considered in the diagnostic evaluation of children with myelination abnormalities, iron deposition, developmental delay, and epilepsy depending on the age at evaluation.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Portadoras / Discapacidades del Desarrollo / Enfermedades Desmielinizantes / Distrofias Neuroaxonales / Trastornos del Metabolismo del Hierro / Epilepsia Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pediatr Neurol Asunto de la revista: NEUROLOGIA / PEDIATRIA Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Portadoras / Discapacidades del Desarrollo / Enfermedades Desmielinizantes / Distrofias Neuroaxonales / Trastornos del Metabolismo del Hierro / Epilepsia Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pediatr Neurol Asunto de la revista: NEUROLOGIA / PEDIATRIA Año: 2020 Tipo del documento: Article